The National Health Surveillance Agency (ANVISA in Portuguese) thru Resolution No. 2,514/2026 rejects the requests for safety and efficacy evaluation of five food products and substances. The measure affects probiotics and plant extracts that were seeking authorization for commercialization in Brazil.